MS vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
VS
Veritiv Corporation · Industrials
$169.99
-45.0% upside to fair value
Med Conviction
Grade D
QuantHub Verdict
MS has more upside to fair value
(+15.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
VRTV |
| Current Price |
$206.27 |
$169.99 |
| Fair Value Estimate |
$239.00 |
$93.49 |
| Upside to Fair Value |
+15.9%
|
-45.0%
|
| Market Cap |
$325.4B |
$2.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
23.5x
|
5.4x
|
| Price / Sales |
2.6x
|
0.4x
|
| Price / FCF |
—
|
10.4x
|
| Revenue Growth YoY |
+22.4%
|
-19.0%
|
| Gross Margin |
59.7%
|
22.7%
|
| Operating Margin |
20.7%
|
5.9%
|
| Return on Equity |
18.1%
|
48.6%
|
| Dividend Yield |
2.01% |
1.48% |
| FCF Yield |
—
|
9.57%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
| Metric |
MS |
VRTV |
| Zone Low |
$179.25 |
$70.12 |
| Zone High |
$203.15 |
$79.47 |
| In Buy Zone? |
No
|
No
|